Invasive breast cancer is a heterogeneous disease in its presentation, pathological
classification and clinical course. However, there are more than a dozen variants which are …

Primary neuroendocrine carcinoma of the breast (NECB) is characterized with
heterogeneity, rarity, and poor differentiation, which is probably an underestimated subtype …

Neuroendocrine differentiation and prognosis in breast adenocarcinoma Aims:
Neuroendocrine differentiation has been detected, and its prognostic value studied, in a …

Primary pure neuroendocrine breast carcinomas (NEBC) have been considered special
features within conventional breast carcinomas until recently. Indeed, the actual incidence of …

Advances in basic science, technology and translational research have created a revolution
in breast cancer diagnosis and therapy. Researchers' discoveries of genes defining …

Neuroendocrine (NE) breast carcinomas are a rare entity in young women; however, their
frequency increases in aged patients. The present work demonstrates that NE breast …

Neuroendocrine breast carcinoma (NEBC) diagnosis relies on (i) presence of morphologic
neuroendocrine features, and (ii) neuroendocrine markers expressed in more than 50% of …

Mucinous carcinoma is considered a distinct pathological entity. However, mucinous
tumours can be divided into a least two groups: mucinous A (or paucicellular) and mucinous …

Background: Invasive breast cancer (IBC) can be categorized into prognostic and predictive
molecular subtypes (including luminal breast cancer) using gene expression profiling …

Terms such as “mixed endocrine–exocrine carcinoma”(MEEC) and “adenocarcinoma with
neuroendocrine (NE) differentiation”(ADC-NE) identify tumours belonging to the spectrum of …